ARCHITECT ANTI-HCV
Report
- Report Number
- 3002809144-2013-00126
- Event Type
- Malfunction
- Date Received
- May 15, 2013
- Report Date
- May 8, 2013
- Manufacturer
- ABBOTT GERMANY
- Product Code
- MZO
- PMA / PMN Number
- P050042
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- JA
- Reporter Occupation
- OTHER
Narratives
(B)(6). THIS REPORT IS BEING FILED ON AN INTERNATIONAL PRODUCT, ARCHITECT ANTI-HCV, LIST 06C37, THAT HAS A SIMILAR PRODUCT DISTRIBUTED IN THE U.S., ARCHITECT ANTI-HCV, LIST 01L79. A FOLLOW UP REPORT WILL BE SUBMITTED WHEN THE EVALUATION IS COMPLETE.
FURTHER INVESTIGATION OF THE CUSTOMER ISSUE INCLUDED A REVIEW OF THE COMPLAINT TEXT, SPECIFICITY AND SENSITIVITY TESTING, A SEARCH FOR SIMILAR COMPLAINTS, AND A REVIEW OF LABELING. A RETAINED KIT OF (B)(6) REAGENT LOT 23706LI00 WAS CALIBRATED, AND CALIBRATORS AND CONTROLS MET SPECIFICATIONS. TWO HUNDRED NINETY-NINE REPLICATES OF POSITIVE CONTROL ACROSS THREE INSTRUMENTS GENERATED CONTROL VALUES IN THE TYPICAL RANGE. SENSITIVITY PANELS WERE RUN AND MET SPECIFICATIONS. TRACKING AND TRENDING IDENTIFIED NO ADVERSE TRENDS FOR THE CUSTOMER'S ISSUE. LABELING WAS REVIEWED AND FOUND TO BE ADEQUATE. BASED ON THE INVESTIGATION, NO PRODUCT DEFICIENCY WAS IDENTIFIED.
THE CUSTOMER STATED AN ARCHITECT I2000SR ANALYZER GENERATED A (B)(6) RESULT FOR ONE PATIENT SAMPLE. THE ARCHITECT GENERATED AN INITIAL (B)(6) RESULT OF (B)(6). THE SAMPLE WAS RECENTRIFUGED AND GENERATED A (B)(6) RESULT OF (B)(6). THE PATIENT HAD A HISTORY OF (B)(6) RESULTS. THE (B)(6) RESULT WAS NOT REPORTED OUTSIDE THE LABORATORY AND THERE WAS NO ADVERSE IMPACT TO PATIENT MANAGEMENT REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 215571 | ARCHITECT ANTI-HCV | MZO | ABBOTT GERMANY | 23706LI00 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | ARCHITECT I2000SR ANALYZER| ARCHITECT I2000SR ANALYZER| LN 03M74-01 SN (B)(4)| LN 03M74-01 SN (B)(4) |